Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. 2000

D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
Department of Neurology, The Mount Sinai Medical Center, New York, NY, USA.

BACKGROUND Neurological impairment is a major source of morbidity and mortality following orthotopic liver transplantation (OLT). We reviewed our experience with neurologic complications among our first 463 consecutive adult OLT recipients. METHODS Between September 1988 and October 1993, 463 adult patients underwent OLT. Data on incidence, time of onset, and outcome of central nervous system (CNS) complications was obtained from patient charts, including autopsy results when available. CNS complications were classified by clinical presentation and by etiology. RESULTS 93 patients (20.1%) had CNS complications following OLT. Encephalopathy (11.8%) and seizure (8.2%) were the leading complications. The incidence of immunosuppressive drug-related complications was 5.6%; coma, 1.7%; cerebral hemorrhage, 1.5%; central pontine myelinolysis (CPM), 1.2%; stroke, 0.6%; and primary CNS lymphoma, 0.2%. Most CNS events (80%) were encountered in the first month after OLT. In the majority of cases, encephalopathy (70%) and seizure (50%) presented in the first 2 wk. Although most CNS infections occurred early, 2 patients developed tuberculous meningitis more than 1 yr post-OLT. In 12 patients, death was directly related to CNS complications (2.6%). CONCLUSIONS Most CNS complications occur early following OLT but may be seen even after 1 yr. Patients may survive serious neurologic events, such as cerebral hemorrhage, CPM, and meningitis.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001927 Brain Diseases Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM. Intracranial Central Nervous System Disorders,Brain Disorders,CNS Disorders, Intracranial,Central Nervous System Disorders, Intracranial,Central Nervous System Intracranial Disorders,Encephalon Diseases,Encephalopathy,Intracranial CNS Disorders,Brain Disease,Brain Disorder,CNS Disorder, Intracranial,Encephalon Disease,Encephalopathies,Intracranial CNS Disorder
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
November 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
December 2010, Transplantation,
D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
August 2001, Transplantation proceedings,
D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
June 2021, Journal of gastrointestinal and liver diseases : JGLD,
D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
September 2002, Transplantation,
D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
January 1997, Transplantation proceedings,
D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
February 1987, Transplantation proceedings,
D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
August 1994, Transplantation proceedings,
D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
June 1990, Clinics in chest medicine,
D J Bronster, and S Emre, and P Boccagni, and P A Sheiner, and M E Schwartz, and C M Miller
March 1979, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!